cro.directory
← Compare landing

HitGen Inc. vs Pharma Inventor

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/hitgen/pharmainventor

CategoryHitGen Inc.Pharma Inventor
Listed sitebothcro
SummaryHitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.Vancouver-based preclinical drug discovery CRO offering medicinal chemistry, custom synthesis, LC-MS/MS bioanalysis, high-throughput screening and ADC development for pharma and biotech teams. Lists 6,000+ sq ft of research facilities and in-house 400 MHz NMR.
Services
  • Discovery Research
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Oligonucleotide Manufacturing
  • Bioinformatics & Data Science
  • Bioanalysis
  • Analytical Method Development & Validation
  • Preclinical In Vitro Studies
  • Genomics & Sequencing Services
  • Medicinal Chemistry
  • Analytical Method Development & Validation
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • In Vitro ADME / DMPK
  • High-Throughput Screening
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Target Identification & Validation
  • Computational & In-Silico Drug Discovery
  • Discovery Research
Modalities
  • Small Molecule
  • Oligonucleotide
  • Peptide
  • Small Molecule
  • Peptide
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
Indications
  • Oncology
  • Immunology
  • Ophthalmology
  • Infectious Disease
  • Metabolic
  • Cardiovascular
Data not yet provided.
Locations
  • Houston, Houston, United States
  • Headquarters, Chengdu, China
  • Cambridge, Cambridge, United Kingdom
  • Headquarters, Vancouver, British Columbia, Canada
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.